◆ TICKERBASEVue interactive →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

AccueilToutes les actions › MAXHEALTH · English version

Max Healthcare Institute Limited (MAXHEALTH)

Historique du chiffre d'affaires, des bénéfices et des flux de trésorerie d'après les états financiers officiels.

Healthcare · Wall Street (États-Unis) · Dernière mise à jour : 2026-09-20

Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, bone marrow transplant, bariatric/weight loss surgery, gynecology, minimal access/laparoscopic surgery, eye care/ophthalmology, robotic surgery, paediatrics, nephrology, liver and biliary sciences, gastroenterology and GI surgery, internal medicine, organ transplants, and plastic and reconstructive surgery.

Chiffres clés

Voir les graphiques interactifs et les états complets →

Compte de résultat annuel

Compte de résultat2026-03-312025-03-312024-03-312023-03-31
Chiffre d'affaires total₹82.3B₹69.1B₹53.1B₹44.9B
Bénéfice brut₹64.4B₹54.3B₹41.9B₹35.7B
Résultat opérationnel (EBIT)₹18.8B₹15.8B₹12.8B₹10.5B
Résultat net₹14.4B₹10.8B₹10.6B₹11.0B

Source : rapports publics de la société (SEC). Vérifiez sur SEC EDGAR avant de vous fier à tout chiffre.

Bilans, flux de trésorerie, données trimestrielles et ratios complets dans le visualiseur interactif de MAXHEALTH. /companies/us/MAXHEALTH

Entreprises similaires

Les informations de ce site sont fournies à des fins éducatives et informatives uniquement ; elles ne constituent pas un conseil en investissement. Aucun objectif de cours ni recommandation n'est publié.

English version →Toutes les actions

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.